ClearBridge Investments - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 264 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$104,714,010
-7.8%
2,741,922
-0.7%
0.10%
-1.0%
Q2 2023$113,543,228
-27.9%
2,760,594
+0.6%
0.10%
-32.0%
Q1 2023$157,498,534
+8.9%
2,743,399
+6.3%
0.15%
+4.9%
Q4 2022$144,665,702
+33.3%
2,580,091
+0.7%
0.14%
+31.2%
Q3 2022$108,515,000
-21.3%
2,561,731
+0.3%
0.11%
-15.5%
Q2 2022$137,955,000
-15.9%
2,553,297
+0.0%
0.13%
+4.9%
Q1 2022$164,015,000
-3.9%
2,552,366
+0.2%
0.12%
+6.0%
Q4 2021$170,602,000
-2.3%
2,546,676
-0.2%
0.12%
-7.2%
Q3 2021$174,665,000
+0.1%
2,550,601
-0.2%
0.12%
+3.3%
Q2 2021$174,414,000
-1.3%
2,555,897
-0.0%
0.12%
-8.3%
Q1 2021$176,663,000
+6.1%
2,557,005
-0.3%
0.13%
+2.3%
Q4 2020$166,562,000
+36.6%
2,565,643
-0.7%
0.13%
+22.9%
Q3 2020$121,975,000
+0.2%
2,583,116
-0.3%
0.10%
-4.5%
Q2 2020$121,761,000
+4.0%
2,591,221
-1.1%
0.11%
-13.4%
Q1 2020$117,080,000
-22.8%
2,620,990
+0.0%
0.13%
+0.8%
Q4 2019$151,625,000
-3.6%
2,620,089
+0.0%
0.13%
-8.0%
Q3 2019$157,353,000
+11.8%
2,619,501
+4.0%
0.14%
+12.3%
Q2 2019$140,688,000
+3.4%
2,519,027
+3.1%
0.12%
+1.7%
Q1 2019$136,077,000
+49.7%
2,442,164
+21.2%
0.12%
+30.4%
Q4 2018$90,903,000
-23.8%
2,015,586
+11.3%
0.09%
-10.7%
Q3 2018$119,267,000
+10.4%
1,810,641
+7.9%
0.10%
+17.0%
Q2 2018$108,069,000
+50.0%
1,677,836
+28.9%
0.09%
+29.4%
Q1 2018$72,049,000
+16.3%
1,301,930
+0.6%
0.07%
+19.3%
Q4 2017$61,945,000
-4.9%
1,294,287
+0.3%
0.06%
-9.5%
Q3 2017$65,156,000
-7.4%
1,290,726
+0.0%
0.06%
-8.7%
Q2 2017$70,329,000
+29.8%
1,290,202
+0.3%
0.07%
+25.5%
Q1 2017$54,203,000
-0.9%
1,286,557
+101.7%
0.06%
-8.3%
Q4 2016$54,709,000
+3.8%
637,704
-0.1%
0.06%
+1.7%
Q3 2016$52,682,000
+3.4%
638,182
-0.1%
0.06%
-1.7%
Q2 2016$50,968,000
+18.9%
638,854
+0.4%
0.06%
+17.6%
Q1 2016$42,871,000
-2.0%
636,450
-1.4%
0.05%0.0%
Q4 2015$43,745,000
+13.3%
645,390
-0.5%
0.05%
+10.9%
Q3 2015$38,614,000
-14.7%
648,422
-3.6%
0.05%
-4.2%
Q2 2015$45,292,000
+8.7%
672,290
-0.5%
0.05%
+11.6%
Q1 2015$41,666,000
+13.8%
675,843
+0.1%
0.04%
+13.2%
Q4 2014$36,598,000
+9.4%
674,866
+0.2%
0.04%
+2.7%
Q3 2014$33,448,000
+6.2%
673,808
+0.6%
0.04%
+5.7%
Q2 2014$31,506,000
+2.7%
669,487
+0.4%
0.04%
-2.8%
Q1 2014$30,668,000
+2.1%
666,847
+5.9%
0.04%
-2.7%
Q4 2013$30,040,000
+34.0%
629,632
+13.1%
0.04%
+19.4%
Q3 2013$22,414,000
+47.4%
556,864
+34.1%
0.03%
+34.8%
Q2 2013$15,211,000415,2600.02%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q2 2021
NameSharesValueWeighting ↓
VeriStar Capital Management LP 268,000$10,234,9208.72%
Madison Avenue Partners, LP 964,667$36,840,6335.23%
Pavadi Capital LLC 99,999$3,818,9624.97%
KESTREL INVESTMENT MANAGEMENT CORP 122,450$4,6762.96%
Sapience Investments, LLC 245,700$9,383,2832.26%
Ellsworth Advisors, LLC 102,500$3,882,7001.38%
Point72 Europe (London) LLP 464,462$17,737,8041.09%
COOKE & BIELER LP 2,714,194$103,655,0691.01%
TANDEM CAPITAL MANAGEMENT CORP /ADV 75,586$2,886,6300.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,827$43,033,5230.95%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders